Here are relevant reports on : veterinary-telehealth-market
-
Asia Pacific Patient Engagement Solutions Market by Therapy (Chronic [Obesity, Diabetes], Women’s Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing), End User (Hospital, ASC, Payer, Patient), Unmet Need, Investment - Forecast to 2030
The Asia Pacific Patient Engagement Solutions market, valued at USD 3.45 billion in 2024, stood at USD 3.97 billion in 2025 and is projected to advance at a resilient CAGR of 13.5% from 2025 to 2030, culminating in a forecasted valuation of USD 7.48 billion by the end of the period. This growth is driven by the rising demand for patient-centered and personalized care, a rapid expansion of telehealth and remote care frameworks, and more investments in digital healthcare infrastructure within the Asia Pacific region.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Clinical Communication & Collaboration Market By Platform (Voice, Messaging), Component (Badge, Nurse Call, VOIP, Wearable, Alert, Scheduling, Telehealth), Application (Nurse, Lab/Radiology, Patient), End User (Hospitals, ASC) - Global Forecast to 2030
The global clinical communication & collaboration market, valued at US$2,598.1 million in 2024, stood at US$2,876.1 million in 2025 and is projected to advance at a resilient CAGR of 13.02% from 2025 to 2030, culminating in a forecasted valuation of US$5,302.9 million by the end of the period. The clinical communication and collaboration market is experiencing rapid growth, driven by the increasing need for real-time communication and effective care coordination.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
US Patient Engagement Solutions Market by Therapy [Chronic (CVD, Diabetes), Women’s Health], Application (Home & Financial Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing), End User (Hospital, ASC, Payer, Patient) - Forecast to 2030
The US Patient Engagement Solutions market, valued at USD 12.86 billion in 2024, stood at USD 14.55 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of USD 25.01 billion by the end of the period. This growth is driven by increased adoption of digital health technologies, a shift toward value-based models and patient-centered care, the prevalence of chronic diseases, and greater use of smartphones, patient portals, and telehealth solutions.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology), Age (Adults, Pediatrics), End User (Hospitals, ASCs, Payers) - Forecast to 2030
The Asia Pacific telehealth & telemedicine market, valued at US$18.22 billion in 2024, stood at US$21.04 billion in 2025 and is projected to advance at a resilient CAGR of 14.2% from 2024 to 2030, culminating in a forecasted valuation of US$40.83 billion by the end of the period. The growth of the telehealth and telemedicine market in the region is driven by rising demand for remote healthcare delivery, digital health platforms, and virtual care solutions that improve accessibility, efficiency, and cost-effectiveness across diverse population groups.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Rapid Test Market by Product (Rapid Test Kit, Rapid Test Readers), Application (Viral, Bacterial, Parasite, Allergies), and Animal Type (Companion (Cat, Dog, Horse), Livestock (Cattle, Swine, Poultry)) - Global Forecast to 2024
The global veterinary rapid tests market is projected to reach USD 854 million by 2024 from USD 573 million in 2019, at a CAGR of 8.3%. Factors contributing to the growth of this market include the increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases. The prominent players in this market are Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Biopanda Reagents Ltd. (UK), Fassisi GmbH (Germany), Virbac (France), BioNote, Inc. (South Korea), SWISSAVANS AG (Switzerland), MEGACOR Diagnostik GmbH (Austria), and Woodley Equipment Company (UK).
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The US veterinary vaccines market, valued at USD4.39 billion in 2025, stood at USD4.67 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD6.50 billion by the end of the period. This growth is attributed to the increasing awareness regarding animal health as well as the rising pet population and pet ownership. Other emerging trends affecting the growth of this segment are government initiatives to improve the health of animals and increased adoption of pet coverage.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Companion Animal Health Market by Animal Type (Dogs, Cats), Product (Vaccines, Pharmaceuticals, Diagnostics), End User (Veterinary Hospitals & Clinics, Diagnostics Laboratories) - Global Forecast to 2027
The companion animal health market is projected to reach USD 26.9 Billion by 2027 from USD 19.2 Billion in 2022 at a CAGR of 6.9% during the forecast period. The growth in this market is mainly attributed to increasing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. However, increasing pet care costs are expected to hinder market growth to a certain extent.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031
The global veterinary contract manufacturing & research market is projected to reach USD 1.48 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Orthopedics Market by Product (Orthopedic Implants, Instruments, Consumables), Animal Type (Dog, Cat, Horse, Livestock), Application (TPLO, TTA, Fracture Repair), Material (Metallic, Absorbable), End User, and Region - Global Forecast to 2031
The veterinary orthopedics market is projected to reach USD 0.86 billion by 2031 from USD 0.57 billion in 2026, at a CAGR of 8.5% from 2026 to 2031. Market is driven by factors such as growth in companion animal population, growing demand for pet insurance, and rising expenditure on animal healthcare. On the other hand, high cost of veterinary orthopedic devices and procedure is expected to restrain market growth to a some extent during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Veterinary PoC Diagnostics Market by Product (Consumables and Instruments), Technology [Immunodiagnostics, Molecular Diagnostics (Isothermal Amplification, PCR, CRISPR)], Animal Type (Companion Animals, Livestock, Poultry) - Global Forecast to 2031
The global veterinary PoC diagnostics market is projected to reach USD 1.72 billion by 2031, growing at a CAGR of 7.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
